ADAM10 and hepatocellular carcinoma: While ADAM10 also activates Notch signaling, no report involving a Notch-ADAM10 signaling pathway to promote HCC progression has been reported yet, may be due to its ligand-dependency mechanism while ADAM17 activates Notch signaling by a ligand-independent mechanism [7].